Documente Academic
Documente Profesional
Documente Cultură
025 Original Dima Idomir PDF
025 Original Dima Idomir PDF
Abstract:
The aim of our study has consisted in the evaluation of the prevalence and sensitivity to antibiotics of
the ESBL strains from different Enterobacteriaceae genre. The study group has included 630 bacterial
strains producing ESBL, isolated from the samples of the patients hospitalized in the Clinical County
Emergency Hospital of Braşov, between 2008 and 2009.
The detection of multiresistent Enterobacteriaceae strains producing ESBL was based on the synergy
test, done with Oxoid biodiscs (ceftazidime - 30 g and amoxicillin - clavulanic acid - 30 g), confirmed
with the VITEK 2 COMPACT automatized system. The testing of sensitivity to antibiotics of the
Enterobacteriaceae strains producing ESBL was done by the difusimetric Kirby-Bauer method and VITEK 2
COMPACT system.
The highest percentage of the ESBL strains was registered in Escherichia coli (46.2%), followed by
Klebsiella sp. (23.2%) and Enterobacter sp. (20.3%). With lower frequencies have been isolated ESBL strains of
Proteus, Serratia, Citrobacter, Morganella. In vitro, the sensitivity to carbapenems was high, while for
aminoglicosides and fluorochinolones there were obtained higher levels of resistence.
66
Studiu original J.M.B.
68
Studiu original J.M.B.
Figura 1 Etp
96,3
1,3 S
Am analizat şi variaţia spectrului tulpinilor În cazul tulpinilor ESBL din celelalte genuri
ESBL de la un an de studiu la altul. Am evaluat izolate, numărul a fost foarte redus, prin urmare nu
spectrul tulpinilor ESBL depistate în 2008 şi se poate face o analiză semnificativă. Au fost
respectiv 2009, aşa cum rezultă din tabelul 2. depistate şi în aceste situaţii tulpini rezistente sau
intermediar sensibile la carbapenemele testate
Genuri/specii Ponderea Ponderea (Proteus sp. rezistente: imipenem -1, meropenem -
bacteriene tulpinilor tulpinilor 1, ertapenem -1; Proteus sp. intermediar sensi-
ESBL în ESBL în bile: ertapenem -1; Morganella species rezisten-
2008 2009 te: imipenem - 1, meropenem -1, ertapenem - 1).
Escherichia coli 47.3% 48.6% Figura 6 ilustrează comportamentul
Klebsiella sp. 20.7% 24.4% tulpinilor ESBL ce au fost testate la
Enterobacter sp. 25.4% 17.7% aminoglicozide.
Proteus sp. 3.5% 4.4%
Serratia sp. 1% 2.7%
Citrobacter sp. 0.5% 0.5%
Morganella sp. 1.6% 0.7%
Tabelul 2.
69
Studiu original J.M.B.
70
Studiu original J.M.B.
14. Livermore D.M., Canton R., et al - CTX-M: Journal of Medical Microbiology, vol 300,
changing the face of ESBLs in Europe, issue 6, 2010, pg. 371-379.
Journal of Antimicrobial Chemotherapy, 18. Pitout J.D., Laupland K.B. – Extended -
vol. 59, 2007, pg. 165-174. spectrum beta - lactamase-producing
15. Paterson D.L., Bonomo R.A. - Extended- Entero-bacteriaceae: an emerging public
spectrum beta-lactamases: a clinical update, health concern. Lancet Infectious Diseases,
Clinical Microbiology Reviews, vol. 18, vol. 8, 2008, pg. 159-166.
2005, pg. 657-686. 19. Ruppé E. - Épidémiologie des bêta-
16. Peterson L.R. - Antibiotic policy and lactamases à spectre élargi: l’avènement des
prescribing strategies for therapy of CTX-M, Antibiotiques, vol 12, issue 1,
extended-spectrum beta-lactamase-producing 2010, pg. 3-16.
Enterobacteriaceae: the role of piperacillin- 20. Trecarichi E.M., Tumbarello M., et al -
tazobactam. Clinical Microbiology and Incidence and clinical impact of extended
Infection, vol. 14 (Suppl. 1), 2008, pg. 181- spectrum-b-lactamase (ESBL) production and
184. fluoroquinolone resistance in bloodstream
17. Pfeifer Y., Cullik A., Witte W. - Resistance to infections caused by Escherichia coli in
cephalosporins and carbapenems in Gram- patients with hematological malignancies,
negative bacterial pathogens, International Journal of Infection, vol.58, 2009, pg. 299-
307.
72